2071 Results

People

  1. Hudis
    Hudis
  2. Norton
    Norton
  3. Zelenetz
    Zelenetz
  4. Yahalom
    Yahalom
  5. Cheung
    Cheung
  6. O'Reilly
    O'Reilly
  7. Kushner
    Kushner
  8. Perales
    Perales
  9. La Quaglia
    La Quaglia
  10. Giralt
    Giralt

Groups

  1. Department of Medicine (1047)
  2. Center for Hematologic Malignancies (589)
  3. Hematologic Malignancies, Division of (537)
  4. Survivorship Research (532)
  5. Solid Tumor Oncology Division (487)
  6. Pediatrics, Department of (383)
  7. Surgery (287)
  8. GSK Faculty (276)
  9. Breast Medicine Service (255)
  10. Tow Center for Developmental Oncology (TCDO) (240)
  1. "cyclophosphamide"
Formats
  1. Journal Article (1932)
  2. Review (52)
  3. Conference Paper (46)
  4. Editorial (11)
  5. Research Letter (11)
  6. Meeting Abstract (8)
  7. Correspondence (6)
  8. Guidelines (4)
  9. Book Section (1)
Groups
  1. Department of Medicine (1047)
  2. Center for Hematologic Malignancies (589)
  3. Hematologic Malignancies, Division of (537)
  4. Survivorship Research (532)
  5. Solid Tumor Oncology Division (487)
  6. Pediatrics, Department of (383)

More Groups

People
  1. Clifford Hudis (130)
  2. Larry Norton (104)
  3. Andrew Zelenetz (75)
  4. Joachim Yahalom (72)
  5. Nai-Kong Cheung (71)
  6. Richard O'Reilly (67)

More People

Years
  1. 2025 (45)
  2. 2024 (86)
  3. 2023 (56)
  4. 2022 (44)
  5. 2021 (23)
  6. 2020 (46)

More Years

Publications
  1. Journal of Clinical Oncology (155)
  2. Cancer (109)
  3. Blood (81)
  4. Leukemia and Lymphoma (50)
  5. Biology of Blood and Marrow Transplantation (49)
  6. Bone Marrow Transplantation (48)

More Publications

Publishers
  1. Elsevier Inc. (345)
  2. American Society of Clinical Oncology (163)
  3. Wiley Blackwell (150)
  4. Springer (147)
  5. American Society of Hematology (113)
  6. Lippincott Williams & Wilkins (112)

More Publishers

Results (2071)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A platform trial of neoadjuvant and adjuvant antitumor vaccination alone or in combination with PD-1 antagonist and CD137 agonist antibodies in patients with resectable pancreatic adenocarcinoma
    Journal Article

    Heumann, T.; Judkins, C.; Li, K.; Lim, S. J.; Hoare, J.; Parkinson, R.; Cao, H.; Zhang, T.; Gai, J.; Celiker, B.; more...
    Nature Communications (2023)

    Fulltext@MSK | Save
  • Role of NKG2D ligands and receptor in haploidentical related donor hematopoietic cell transplantation
    Journal Article

    Petersdorf, E. W.; McKallor, C.; Malkki, M.; He, M.; Spellman, S. R.; Hsu, K. C.; Strong, R. K.; Gooley, T.; Stevenson, P.
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Impact of second primary malignancy post–autologous transplantation on outcomes of multiple myeloma: A CIBMTR analysis
    Journal Article

    Ragon, B. K.; Shah, M. V.; D’Souza, A.; Estrada-Merly, N.; Gowda, L.; George, G.; de Lima, M.; Hashmi, S.; Kharfan-Dabaja, M. A.; Majhail, N. S.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Quality-adjusted time without symptoms or toxicity: Analysis of axicabtagene ciloleucel versus standard of care in patients with relapsed/refractory large B cell lymphoma
    Journal Article

    Kersten, M. J.; Qiao, Y.; Shah, R.; Solem, C.; Snider, J. T.; To, C.; Cheng, P.; Spooner, C.; Perales, M. A.
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Is local review of positron emission tomography scans sufficient in diffuse large B-cell lymphoma clinical trials? A CALGB 50303 analysis
    Journal Article

    Torka, P.; Pederson, L. D.; Knopp, M. V.; Poon, D.; Zhang, J.; Kahl, B. S.; Higley, H. R.; Kelloff, G.; Friedberg, J. W.; Schwartz, L. H.; more...
    Cancer Medicine (2023)

    Fulltext@MSK | Save
  • Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL
    Journal Article

    Ruan, J.; Moskowitz, A.; Mehta-Shah, N.; Sokol, L.; Chen, Z.; Kotlov, N.; Nos, G.; Sorokina, M.; Maksimov, V.; Sboner, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Preoperative immunotherapy combined with chemotherapy for triple-negative breast cancer: Perspective on the KEYNOTE-522 study
    Editorial

    Downs-Canner, S.; Mittendorf, E. A.
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Outcomes with high dose cytarabine and mitoxantrone induction for adults with mixed phenotype acute leukemia
    Journal Article

    Atchley, E.; Weis, T. M.; Derkach, A.; Galera, P. K.; Xiao, W.; Glass, J.; DeWolf, S.; Roshal, M.; Shah, R.; Stump, S. E.
    Leukemia Research (2023)

    Fulltext@MSK | Save
  • Bridging radiation rapidly and effectively cytoreduces high-risk relapsed/refractory aggressive B cell lymphomas prior to chimeric antigen receptor T cell therapy
    Journal Article

    Hubbeling, H.; Silverman, E. A.; Michaud, L.; Tomas, A. A.; Shouval, R.; Flynn, J.; Devlin, S.; Wijetunga, N. A.; Tringale, K. R.; Batlevi, C.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Moving towards biologically informed treatment strategies for T-cell lymphomas
    Review

    Stuver, R.; Lewis, N.; Dogan, A.; Horwitz, S. M.
    International Journal of Hematology (2023)

    Fulltext@MSK | Save